{"nct_id":"NCT02337725","title":"A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2015-02-07","start_date_type":"ACTUAL","primary_completion_date":"2016-09-15","primary_completion_date_type":"ACTUAL","completion_date":"2016-09-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TAK"]}